AstraZeneca engages in the research, development, clinical testing, and manufacturing of prescription drugs. Its R&D pipeline focuses on complex disease areas such as oncology, cardiovascular, renal, and respiratory systems. The business covers the synthesis of active pharmaceutical ingredients, regulatory submissions for human trials, and the commercialized production of medicines. Approved drugs are supplied at scale to medical institutions and pharmacies worldwide through specialized distribution networks.